Edwards Lifesciences | EW - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 24.93B 934M 2026-06
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
ICU Medical USD 2.11B 11.9M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.68B 53.08M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03